PRESENTATION II NAME

53
PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator

description

PRESENTATION II NAME. Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator. By Christine Harvey. Dihydrofolate Reductase in Escherichia coli. Class: oxidoreductase Reduces dihydrofolate (DHF) to tetrahydrofolate (THF) - PowerPoint PPT Presentation

Transcript of PRESENTATION II NAME

Page 1: PRESENTATION II  NAME

PRESENTATION II NAME

By Christine Harvey

Dihydrofolate Reductase Beta lactmasep300Macrophage Infectivity Potentiator

Page 2: PRESENTATION II  NAME

Dihydrofolate Reductase

in Escherichia coli

Page 3: PRESENTATION II  NAME

http://en.wikipedia.org/wiki/DHFR

• Class: oxidoreductase

• Reduces dihydrofolate (DHF) to tetrahydrofolate (THF)

• THF is a precursor to amino acids, purine and thymidylate.

• DHFR is imperative to cell life

Page 4: PRESENTATION II  NAME

Function

Source: Schweitzer, Barry I., et al. The FASEB Journal Vol 4, “Dihydrofolate reductase as a therapeutic target.” May 1990.

Page 5: PRESENTATION II  NAME

Mechanism

http://en.wikipedia.org/wiki/DHFR

Page 6: PRESENTATION II  NAME

Structure

Page 7: PRESENTATION II  NAME

Binding Pocket

Page 8: PRESENTATION II  NAME
Page 10: PRESENTATION II  NAME
Page 11: PRESENTATION II  NAME
Page 12: PRESENTATION II  NAME
Page 13: PRESENTATION II  NAME
Page 14: PRESENTATION II  NAME

Sequence Alignment

Page 15: PRESENTATION II  NAME

Phylogenetic Tree

Page 16: PRESENTATION II  NAME

Beta-Lactamasein Escherichia coli

Page 17: PRESENTATION II  NAME

• Class: Hydrolase

• Beta Lactamase is produce by bacteria after being exposed to beta lactam antibiotics

• Responsible for beta lactam antibiotic resistance

Page 18: PRESENTATION II  NAME

Penicillin

• Contains beta lactam ring

Page 19: PRESENTATION II  NAME

Mechanism

Page 20: PRESENTATION II  NAME
Page 21: PRESENTATION II  NAME

21

Page 22: PRESENTATION II  NAME
Page 23: PRESENTATION II  NAME
Page 24: PRESENTATION II  NAME
Page 25: PRESENTATION II  NAME
Page 26: PRESENTATION II  NAME
Page 27: PRESENTATION II  NAME
Page 28: PRESENTATION II  NAME

p300In Homo Sapiens

Page 29: PRESENTATION II  NAME

• Class: Transferase

• p300 transfers an acetyl group from acetyl coenzyme A to an active site lysine

• Transcriptional activation occurs upon acetyl transfer

Page 30: PRESENTATION II  NAME

Title

• p300 is responsible for cell growth before and after birth

• Cancer suppressor

Page 31: PRESENTATION II  NAME

Domains

Taz2

KIX

Bromodomain

HAT

Zinc Fingers (3)

Taz2

Creb

Page 32: PRESENTATION II  NAME

Histone Acetyl Transferase

• Active site tyrosine acts as nucleophile

Source: http://www.bmolchem.wisc.edu/labs/denu/images/hats/sequential.jpg

Page 33: PRESENTATION II  NAME
Page 34: PRESENTATION II  NAME
Page 35: PRESENTATION II  NAME
Page 36: PRESENTATION II  NAME
Page 37: PRESENTATION II  NAME

Docking

Page 38: PRESENTATION II  NAME
Page 39: PRESENTATION II  NAME

39

Page 40: PRESENTATION II  NAME

Macrophage Infectivity Potentiator

in Legionella pneumophila

Page 41: PRESENTATION II  NAME

Legionella pneumophila

• gram negative bacteria

• Causes Legionnaires’ disease

• Carried in aerosols from man-made water systems

Page 42: PRESENTATION II  NAME

MIP

• Class: Isomerase

• Catalyzes the isomeration of the N-terminal on proline

• Cause of virulence in Legionnaires’ disease

• Located on outer membrane protein

• 25 kDa

Page 43: PRESENTATION II  NAME

Crystalization

• Solution: 100 mM MES (pH 6.1–6.5), 15–20% (w/v) PEG 8000 and 500 mM zinc acetate. Protein concentration was 10 mg ml–1in 20 mM HEPES, pH 7.0

• Crystals were grown for 2-3 weeks at 288K

• X-ray data was collected at 100K in a nitrogen gas stream (dried paraffin oil) at 2.4 Angstrom resolution

• Multiwavelength anomalous dispersion (MAD) with zinc was used for phasing

Page 44: PRESENTATION II  NAME

44

Source: Riboldi-Tunnicliffe, Alan et al., Nature Structural Biology, vol.8: 9. “Crystal structure of Mip, a prolylisomerase from Legionella pneumophila.” September 2001.

Page 45: PRESENTATION II  NAME

Mechanism

• Peptidyl-prolyl cis-trans isomerases’ (PPIases) mechanism is not currently know

Source: Park, Steven T., et al. Journal of Biological Chemistry. Vol. 267 No.5, “PPIase Catalysis by Human Fk506-binding Protein Proceeds Through a Conformational Twist Mechanism.” February 1992.

Page 46: PRESENTATION II  NAME

Source: Riboldi-Tunnicliffe, Alan et al., Nature Structural Biology, vol.8: 9. “Crystal structure of Mip, a prolylisomerase from Legionella pneumophila.” September 2001.

Page 47: PRESENTATION II  NAME
Page 48: PRESENTATION II  NAME
Page 49: PRESENTATION II  NAME

49

Page 50: PRESENTATION II  NAME
Page 51: PRESENTATION II  NAME

51

Page 52: PRESENTATION II  NAME

52

Page 53: PRESENTATION II  NAME

53

Questions?